The Effects of Testicular Cancer Treatment on Health-related Quality of Life

Urology

Volumn 75, Issue 3, 2010, Pages 636-641

  Vidrine, Damon J ^a   Hoekstra Weebers, Josette E H M ^b,c   Hoekstra, Harald J ^b   Tuinman, Marrit A ^b   Marani, Salma ^a   Gritz, Ellen R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c Integraal Kankercentrum Noord Nederland   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CLINICAL ASSESSMENT; COMPARATIVE STUDY; DEMOGRAPHY; FATIGUE; FOLLOW UP; HEALTH STATUS; HEALTH SURVEY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NETHERLANDS; ORCHIECTOMY; PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SCORING SYSTEM; SOCIAL STATUS; SURVIVAL RATE; TESTIS CANCER; THERAPY EFFECT; UNITED STATES;

ADULT; CHEMOTHERAPY, ADJUVANT; HUMANS; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; ORCHIECTOMY; PROSPECTIVE STUDIES; QUALITY OF LIFE; TESTICULAR NEOPLASMS;

EID: 77649182952     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.09.053     Document Type: Article

References (30)

1. In: Ries L.A.G., Melbert D., Krapcho M., et al. (Eds). SEER Cancer Statistics Review, 1975-2005, based on November 2007 SEER Data Submission (2008), National Cancer Institute, Bethesda, MD. http://seer.cancer.gov/csr/1975_2005/, based on November 2007 SEER data submission, posted to the SEER web site
2. Ferlay J., Bray F., Pisani P., et al. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5, Version 2.0. http://www-depdb.iarc.fr/globocan2002.htm Accessed March 6, 2009
3. Richiardi L., Bellocco R., Adami H.O., et al. Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 13 (2004) 2157-2166
4. Huyghe E., Matsuda T., and Thonneau P. Increasing incidence of testicular cancer worldwide: a review. J Urol 170 (2003) 5-11
5. American Cancer Society. Cancer Facts and Figures 2008 (2008), American Cancer Society, Atlanta, GA
6. Raghavan D. Atlas of clinical oncology: germ cell tumors. In: Steele G.D., Phillips T.L., Chabner B.A., et al. (Eds). American Cancer Society (2003), BC Decker Inc, London
7. Motzer R.J., Bolger G.B., Boston B., et al. Testicular cancer. Clinical practice guidelines in oncology. J Natl Compr Cancer Netw 4 (2006) 1038-1058
8. Efstathiou E., and Logothetis C.J. Review of late complications of treatment and late relapse in testicular cancer. J Natl Compr Cancer Netw 4 (2006) 1059-1070
9. Gritz E.R., Wellisch D.K., and Landsverk J.A. Psychosocial sequelae in long-term survivors of testicular cancer. J Psychosoc Oncol 6 (1988) 41-63
10. Dahl A.A., Mykletun A., and Fossa S.D. Quality of life in survivors of testicular cancer. Urol Oncol 23 (2005) 193-200
11. Fleer J., Hoekstra H.J., Sleijfer D.T., et al. Quality of life of survivors of testicular germ cell cancer: a review of the literature. Support Care Cancer 12 (2004) 476-486
12. Grossfeld G.D., and Small E.J. Long-term side effects of treatment for testis cancer. Urol Clin North Am 25 (1998) 503-515
13. Miyake H., Muramaki M., Eto H., et al. Health-related quality of life in patients with testicular cancer: a comparative analysis according to therapeutic modalities. Oncol Rep 12 (2004) 867-870
14. Arai Y., Ishitoya S., Okubo K., et al. Nerve-sparing retroperitoneal lymph node dissection for metastatic testicular cancer. Int J Urol 4 (1997) 487-492
15. Joly F., Heron J.F., Kalusinski L., et al. Quality of life in long-term survivors of testicular cancer: a population-based case-control study. J Clin Oncol 20 (2002) 73-80
16. Fossa S.D., de Wit R., Roberts J.T., et al. Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20). J Clin Oncol 21 (2003) 1107-1118
17. Fleer J., Hoekstra H.J., Sleijfer D.T., et al. Quality of life of testicular cancer survivors and the relationship with sociodemographics, cancer-related variables, and life events. Support Care Cancer 14 (2006) 251-259
18. Aass N., Grunfeld B., Kaalhus O., et al. Pre- and post-treatment sexual life in testicular cancer patients: a descriptive investigation. Br J Cancer 67 (1993) 1113-1117
19. Trask P.C., Paterson A.G., Fardig J., et al. Course of distress and quality of life in testicular cancer patients before, during, and after chemotherapy: results of a pilot study. Psychooncology 12 (2003) 814-820
20. Dahl A.A., Haaland C.F., Mykletun A., et al. Study of anxiety disorder and depression in long-term survivors of testicular cancer. J Clin Oncol 23 (2005) 2389-2395
21. Fossa S.D., Dahl A.A., and Loge J.H. Fatigue, anxiety, and depression in long-term survivors of testicular cancer. J Clin Oncol 21 (2003) 1249-1254
22. Tuinman MA, Hoekstra HJ, Vidrine DJ, et al. Sexual function, depressive symptoms and marital status in nonseminoma testicular cancer patients: a longitudinal study. Psychooncology. In press.
23. Hays R.D., and Shapiro M.F. An overview of generic health-related quality of life measures for HIV research. Qual Life Res 1 (1992) 91-97
24. Stewart A.L., and Ware Jr. J.E. Measuring Functioning and Well-Being: The Medical Outcomes. Study Approach (1992), Duke University Press, Durham: NC
25. Ware Jr. J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30 (1992) 473-483
26. Radloff L.S. The CES-D scale. A self-report depression scale for research in the general population. Appl Psych Meas 1 (1977) 385-401
27. Spielberger C.D., Gorsuch R., and Lushene R.E. STAI Manual for the State-Trait Anxiety Inventory (1970), Consulting Psychologists Press, Palo Alto, CA
28. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 15 (1997) 594-603
29. Kenward M.G., and Rogers J.H. Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 53 (1997) 983-997
30. Mykletun A., Dahl A.A., Haaland C.F., et al. Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer. J Clin Oncol 23 (2005) 3061-3068